Sposato Luigi A, Lam Yick, Karapetis Chris, Vatandoust Sina, Roy Amitesh, Hakendorf Paul, Dwyer Andrew, de Fontgalland Dayan, Hollington Paul, Wattchow David
Department of Surgery, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia.
Department of Medical Oncology, Flinders Medical Centre, Flinders University, Bedford Park, South Australia, Australia.
Asia Pac J Clin Oncol. 2018 Dec;14(6):439-445. doi: 10.1111/ajco.12993. Epub 2018 Jun 22.
Observation with close follow-up ("watch and wait") is a recognized treatment option in patients who achieve a complete clinical response to long course chemoradiotherapy. This review of a prospective database aims to evaluate the clinical outcomes among patients with a complete clinical response managed with observation.
A prospective study of 32 patients who achieved a complete clinical response was undertaken. The primary outcomes measured were overall and recurrence-free survival, and rate of organ preservation in patients who deferred immediate surgery.
Seven patients developed local regrowth over a median follow-up period of 38 months (range, 9-91 months). Median time to detection was 12 months. All seven underwent salvage surgery with complete surgical clearance. One patient developed combined local and systemic recurrence following a low anterior resection. Organ preservation was possible in 25 (78%) patients who sustained a complete clinical response with no evidence of local regrowth or disease recurrence. Among the patients who sustained a complete response, two developed isolated systemic disease. Overall and recurrence-free survival was 95.7% and 87.0%, respectively.
The majority of patients with rectal cancer who achieved a complete clinical response after chemoradiotherapy and managed with a "watch and wait" approach preserved their rectum and did not develop cancer relapse. Salvage surgery was achieved in all patients who developed local regrowth. The study supports a period of observation in rectal cancer patients who achieve a complete clinical response.
对于在接受长疗程放化疗后获得完全临床缓解的患者,密切随访观察(“观察等待”)是一种公认的治疗选择。本前瞻性数据库综述旨在评估采用观察治疗的完全临床缓解患者的临床结局。
对32例获得完全临床缓解的患者进行了一项前瞻性研究。主要测量的结局指标为总生存率和无复发生存率,以及推迟即刻手术患者的器官保留率。
在中位随访期38个月(范围9 - 91个月)内,7例患者出现局部复发。检测到复发的中位时间为12个月。所有7例均接受了挽救性手术且手术切缘阴性。1例患者在低位前切除术后出现局部和全身联合复发。25例(78%)获得完全临床缓解且无局部复发或疾病复发证据的患者实现了器官保留。在获得完全缓解的患者中,2例出现孤立性全身疾病。总生存率和无复发生存率分别为95.7%和87.0%。
大多数直肠癌患者在放化疗后获得完全临床缓解并采用“观察等待”方法治疗,保留了直肠且未发生癌症复发。所有出现局部复发的患者均成功进行了挽救性手术。该研究支持对获得完全临床缓解的直肠癌患者进行一段时间的观察。